(Q31832576)

English

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 July 2017

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients (English)

1 reference

Europe PubMed Central

4 July 2017

1 reference

based on heuristic

inferred from title

author name string

Jungers P

1

1 reference

Europe PubMed Central

4 July 2017

Choukroun G

2

1 reference

Europe PubMed Central

4 July 2017

Oualim Z

3

1 reference

Europe PubMed Central

4 July 2017

Robino C

4

1 reference

Europe PubMed Central

4 July 2017

Nguyen AT

5

1 reference

Europe PubMed Central

4 July 2017

Man NK

6

1 reference

Europe PubMed Central

4 July 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

4 July 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

4 July 2017

16

1 reference

Europe PubMed Central

4 July 2017

2

1 reference

Europe PubMed Central

4 July 2017

307-312

1 reference

Europe PubMed Central

4 July 2017

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.2.307

21 January 2018

Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.2.307

21 January 2018

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.2.307

21 January 2018

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.2.307

21 January 2018

Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.2.307

21 January 2018

Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.2.307

21 January 2018

Identifiers

10.1093/NDT/16.2.307

1 reference

Europe PubMed Central

4 July 2017

1 reference

Europe PubMed Central

4 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31832576&oldid=1542210389"